News | Ventricular Assist Devices (VAD) | June 23, 2022

Medtronic Recalls HeartWare HVAD System Batteries Due to Battery Failure

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that allow separation of the two cell battery packs used to power the system

June 23, 2022 — Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that allow separation of the two cell battery packs used to power the system. The welding defect may cause the battery to malfunction and no longer provide power or prevent the battery from holding a full charge or properly recharging.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Recalled Product

  • Product Names: Medtronic HVAD Batteries
  • Product Codes: See Recall Database Entry
  • Model Number: 1650DE
  • Manufacturing Dates: April 13, 2021 to April 19, 2021
  • Distribution Dates: April 20, 2021 to July 19, 2021
  • Devices Recalled in the U.S.: 429
  • Date Initiated by Firm: May 5, 2022

Device Use

The HeartWare Ventricular Assist Device (HVAD) System is used to help the heart continue to pump blood to the rest of the body. The HVAD system is used as a bridge to cardiac transplants in patients who are at risk of death from end-stage left ventricular heart failure, for heart tissue recovery, or as destination therapy (DT) in patients for whom heart transplants are not planned.

Reason for Recall

Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that allow separation of the two cell battery packs used to power the system. The welding defect may cause the battery to malfunction and no longer provide power or prevent the battery from holding a full charge or properly recharging. As a result, the battery may fail suddenly.

If this malfunction occurs, it will trigger a Power Disconnect alarm on the controller screen and in the Alarm Log tab of the HVAD Monitor while the affected battery is still connected to the controller. These alarms may temporarily resolve, but the battery will continue to fail.

The use of these batteries may lead to device malfunction, death, or serious injury.

Medtronic reports one death associated with this recall, and two complaints in the affected lot.

Who May be Affected

  • Health care providers treating patients with the Heartware HVAD System
  • Patients who have the Heartware HVAD System implanted

What to Do

On May 5, 2022, Medtronic sent an Urgent Medical Device Correction letter to all affected customers.

  • Immediately identify and quarantine all affected batteries.
  • Immediately notify patients with affected batteries that Medtronic is conducting this retrieval and have them remove these batteries from service. Medtronic has provided a patient template that may be used to communicate directly with patients.
  • Contact a Medtronic Field Representative to assist you in the return of the affected product.
  • Complete the enclosed Customer Confirmation Form and follow the instructions to initiate an exchange. When complete please return the form to [email protected].
  • Share this notice to all those who need to be aware within your organization or to any organization where the affected batteries has been transferred

Medtronic is replacing the affected batteries with new product and has implemented actions to improve control of the welding process.

Contact Information

Health care providers with questions about this recall should contact their local Medtronic Representative.

Patients with questions about this recall should contact Medtronic Patient Services at 800-635-3930 (Monday-Friday, 8 a.m. to 5 p.m. Central time).

For more information: www.fda.gov

Related HVAD Content:

Medtronic Recalls HVAD Pump Implant Kit for Pump Weld Defect

Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries

Class I Recall Issued for Medtronic HeartWare HVAD Pump

Medtronic HeartWare HVAD System Approved for Destination Therapy

FDA, Medtronic Expand HeartWare VAD Recall, Announces New Recall of VAD Component

FDA Announces Two HeartWare HVAD System Class 1 Recalls

New Heart Assist Pump Allows Minimally Invasive Approach at Vanderbilt Heart and Vascular Institute

Related Content

News | Heart Failure

June 29, 2022 — A spiral wave of electrical activity in the heart can cause catastrophic consequences. One spiral wave ...

Home June 29, 2022
Home
News | Heart Failure

June 29, 2022 — Adult survivors of cancer have a higher risk of heart failure and other cardiovascular diseases (CVD) ...

Home June 29, 2022
Home
News | Heart Failure

June 29, 2022 — While lower vertebrates can repair their adult hearts after a heart attack, mammals — including humans — ...

Home June 29, 2022
Home
News | Heart Failure

June 27, 2022 — Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the ...

Home June 28, 2022
Home
News | Heart Failure

June 22, 2022 — Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe ...

Home June 22, 2022
Home
News | Heart Failure

June 22, 2022— Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a ...

Home June 22, 2022
Home
News | Heart Failure

June 20, 2022— Marc Chatzky may not feel like a cardiac pioneer, but he is, at least in South Florida. The Deerfield ...

Home June 20, 2022
Home
News | Heart Failure

June 10, 2022 — Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves ...

Home June 10, 2022
Home
News | Heart Failure

June 9, 2022 — Memorial Regional Hospital recently entered elite company, becoming just the fourth hospital in the ...

Home June 09, 2022
Home
News | Heart Failure

June 3, 3033 — Esperion announced findings from a real-world analysis of more than 400,000 patients at high-risk for ...

Home June 03, 2022
Home
Subscribe Now